29 Apr 2025 22:00 CEST

Issuer

FACEPHI BIOMETRIA S.A

Facephi Ends 2024 Strong with Double-Digit Growth Across Key Metrics: TCV, ARR, Turnover and Ebitda

  • Turnover reached €28.9mm, setting a new high with a 14.8% YoY growth, driven by the launch of new products and services, as well as ongoing diversification into new countries and business verticals.

  • TCV and ARR also set new highs, reaching €57.8mm and €28.0mm, respectively, reflecting 49.5% and 28.5% growth compared to 2023; underscoring the Company’s positive outlook for 2025 and beyond. 

  • Normalized Ebitda reached €1.0mm; a favorable increase of 10.4% compared to €0.9mm in 2023. 

  • Both Cash Flow & Net Financial Debt saw significant improvements versus 2023 

  • Facephi will host a webcast to discuss earnings on Wednesday, May 7, 2025, at 10:00 CT.

april-29-205-paquete-euronext.pdf

Source

FACEPHI

Provider

Euronext

Company Name

FACEPHI

ISIN

ES0105029005

Symbol

ALPHI

Market

Euronext Growth